Exemestane Is Superior to Megestrol Acetate After Tamoxifen Failure in Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Randomized Double-Blind Trial
KAUFMANN, M, BAJETTA, E, FOWST, C, POLLI, A, DI SALLE, E, ARKHIPOV, A, PISCITELLI, G, MILLER, L. L, MASSIMINI, G, DIRIX, L. Y, FEIN, L. E, JONES, S. E, ZILEMBO, N, DUGARDYN, J.-L, NASURDI, C, MENNEL, R. G, CERVEK, J
Published in Journal of clinical oncology (07.04.2000)
Published in Journal of clinical oncology (07.04.2000)
Get full text
Journal Article
P1-17-01: Figitumumab Plus Exemestane Versus Exemestane as First-Line Treatment of Postmenopausal Hormone Receptor-Positive Advanced Breast Cancer: A Randomized, Open-Label Phase II Trial
Ryan, PD, Neven, P, Blackwell, KL, Dirix, LY, Barrios, CH, Miller, WH, Fein, LE, Fenton, D, Benner, RJ, Meech, SJ, Paccagnella, L, Sleight, B, Yee, D, Goss, PE
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Get full text
Journal Article
Ixabepilone plus capecitabine vs capecitabine in patients with metastatic breast cancer receiving ixabepilone in the first line setting: a pooled analysis from two phase III studies
Vahdat, L, Fein, LE, Karwal, MW, Campone, M, Peck, R, Mukhopadhyay, P, Jassem, J
Published in Cancer research (Chicago, Ill.) (15.01.2009)
Published in Cancer research (Chicago, Ill.) (15.01.2009)
Get full text
Journal Article
Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen: results of a double-blind randomised phase III trial
Kaufmann, M, Bajetta, E, Dirix, L.Y, Fein, L.E, Jones, S.E, Cervek, J, Fowst, C, Polli, A, Di Salle, E, Massimini, G, Piscitelli, G
Published in European journal of cancer (1990) (01.09.2000)
Published in European journal of cancer (1990) (01.09.2000)
Get full text
Journal Article